Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and renal outcomes: prevalent user designs may overestimate benefit
- PMID: 25285737
- DOI: 10.1001/jamainternmed.2014.1585
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and renal outcomes: prevalent user designs may overestimate benefit
Comment in
-
Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker use and renal outcomes-reply.JAMA Intern Med. 2014 Oct;174(10):1706-7. doi: 10.1001/jamainternmed.2014.1578. JAMA Intern Med. 2014. PMID: 25285739 No abstract available.
Comment on
-
Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.JAMA Intern Med. 2014 Mar;174(3):347-54. doi: 10.1001/jamainternmed.2013.12700. JAMA Intern Med. 2014. PMID: 24343093
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical